Search research articles
Contact Us
Filters
Showing results (271-280 of 290) with videos related to
Page
of 29
Sort By:
Gastroenterology
|
December 24, 2017
Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia
Sravanthi Parasa, Sreekar Vennalaganti, Srinivas Gaddam, et al.
Gastroenterology
|
December 19, 2016
Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy
Prashanthi N Thota, Prashanth Vennalaganti, Sreekar Vennelaganti, et al.
The New England Journal of Medicine
|
August 2, 1990
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group
R P Perrillo, E R Schiff, G L Davis, et al.
Gastroenterology
|
May 30, 2013
Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort
Srinivas Gaddam, Mandeep Singh, Gokulakrishnan Balasubramanian, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 28, 2013
Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia
Rajeswari Anaparthy, Srinivas Gaddam, Vijay Kanakadandi, et al.
Gastrointestinal Endoscopy
|
October 21, 2018
Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium
Madhav Desai, David A Lieberman, Kevin F Kennedy, et al.
Journal of Clinical Gastroenterology
|
May 8, 2020
Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women
James E Allen, Madhav Desai, Carlijn A M Roumans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 1, 2010
Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma
Sachin Wani, Gary Falk, Matthew Hall, et al.
Endoscopy
|
April 25, 2015
Clinical outcomes in patients with a diagnosis of "indefinite for dysplasia" in Barrett's esophagus: a multicenter cohort study
Preetika Sinh, Rajeswari Anaparthy, Patrick E Young, et al.
Gastroenterology
|
July 5, 2011
Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus
Sachin Wani, Gary W Falk, Jane Post, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 290) with videos related to
Sort By:
Page
of 29
Gastroenterology
|
December 24, 2017
Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia
Sravanthi Parasa, Sreekar Vennalaganti, Srinivas Gaddam, et al.
Gastroenterology
|
December 19, 2016
Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy
Prashanthi N Thota, Prashanth Vennalaganti, Sreekar Vennelaganti, et al.
The New England Journal of Medicine
|
August 2, 1990
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group
R P Perrillo, E R Schiff, G L Davis, et al.
Gastroenterology
|
May 30, 2013
Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort
Srinivas Gaddam, Mandeep Singh, Gokulakrishnan Balasubramanian, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 28, 2013
Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia
Rajeswari Anaparthy, Srinivas Gaddam, Vijay Kanakadandi, et al.
Gastrointestinal Endoscopy
|
October 21, 2018
Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium
Madhav Desai, David A Lieberman, Kevin F Kennedy, et al.
Journal of Clinical Gastroenterology
|
May 8, 2020
Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women
James E Allen, Madhav Desai, Carlijn A M Roumans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 1, 2010
Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma
Sachin Wani, Gary Falk, Matthew Hall, et al.
Endoscopy
|
April 25, 2015
Clinical outcomes in patients with a diagnosis of "indefinite for dysplasia" in Barrett's esophagus: a multicenter cohort study
Preetika Sinh, Rajeswari Anaparthy, Patrick E Young, et al.
Gastroenterology
|
July 5, 2011
Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus
Sachin Wani, Gary W Falk, Jane Post, et al.
Page
of 29